159 related articles for article (PubMed ID: 20882608)
1. Predicting survival in glioblastomas using diffusion tensor imaging metrics.
Saksena S; Jain R; Narang J; Scarpace L; Schultz LR; Lehman NL; Hearshen D; Patel SC; Mikkelsen T
J Magn Reson Imaging; 2010 Oct; 32(4):788-95. PubMed ID: 20882608
[TBL] [Abstract][Full Text] [Related]
2. Fractional Anisotropy Correlates with Overall Survival in Glioblastoma.
Huber T; Bette S; Wiestler B; Gempt J; Gerhardt J; Delbridge C; Barz M; Meyer B; Zimmer C; Kirschke JS
World Neurosurg; 2016 Nov; 95():525-534.e1. PubMed ID: 27565465
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor and dynamic susceptibility contrast MRI in glioblastoma.
Zikou AK; Alexiou GA; Kosta P; Goussia A; Astrakas L; Tsekeris P; Voulgaris S; Malamou-Mitsi V; Kyritsis AP; Argyropoulou MI
Clin Neurol Neurosurg; 2012 Jul; 114(6):607-12. PubMed ID: 22266399
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics.
Ma L; Song ZJ
Clin Neurol Neurosurg; 2013 Dec; 115(12):2489-95. PubMed ID: 24183513
[TBL] [Abstract][Full Text] [Related]
5. Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.
Mohan S; Wang S; Coban G; Kural F; Chawla S; O'Rourke DM; Poptani H
Eur J Radiol; 2019 Mar; 112():106-111. PubMed ID: 30777198
[TBL] [Abstract][Full Text] [Related]
6. Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
Wang S; Martinez-Lage M; Sakai Y; Chawla S; Kim SG; Alonso-Basanta M; Lustig RA; Brem S; Mohan S; Wolf RL; Desai A; Poptani H
AJNR Am J Neuroradiol; 2016 Jan; 37(1):28-36. PubMed ID: 26450533
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of regional DTI-derived tensor metrics in glioblastoma multiforme: simultaneous evaluation of p, q, L, Cl, Cp, Cs, RA, RD, AD, mean diffusivity and fractional anisotropy.
Cortez-Conradis D; Favila R; Isaac-Olive K; Martinez-Lopez M; Rios C; Roldan-Valadez E
Eur Radiol; 2013 Apr; 23(4):1112-21. PubMed ID: 23085868
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging.
Toh CH; Wei KC; Ng SH; Wan YL; Lin CP; Castillo M
AJNR Am J Neuroradiol; 2011 Oct; 32(9):1646-51. PubMed ID: 21835939
[TBL] [Abstract][Full Text] [Related]
10. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
[TBL] [Abstract][Full Text] [Related]
11. Perfusion Parameter Obtained on 3-Tesla Magnetic Resonance Imaging and the Ki-67 Labeling Index Predict the Overall Survival of Glioblastoma.
Fudaba H; Momii Y; Matsuta H; Onishi K; Kawasaki Y; Sugita K; Shimomura T; Fujiki M
World Neurosurg; 2021 May; 149():e469-e480. PubMed ID: 33567368
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.
Byrnes TJ; Barrick TR; Bell BA; Clark CA
NMR Biomed; 2011 Jan; 24(1):54-60. PubMed ID: 20665905
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
[TBL] [Abstract][Full Text] [Related]
14. A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.
Paldino MJ; Desjardins A; Friedman HS; Vredenburgh JJ; Barboriak DP
Br J Radiol; 2012 Apr; 85(1012):382-9. PubMed ID: 21224297
[TBL] [Abstract][Full Text] [Related]
15. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric and multiregional diffusion features help predict molecule information, grade and survival in lower-grade gliomas: a feasibility study.
Lin H; Xu Y; Chen L; Na P; Li W
Br J Radiol; 2019 Nov; 92(1103):20190324. PubMed ID: 31386559
[TBL] [Abstract][Full Text] [Related]
17. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
18. Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma: a pilot study.
Flores-Alvarez E; Anselmo Rios Piedra E; Cruz-Priego GA; Durand-Muñoz C; Moreno-Jimenez S; Roldan-Valadez E
Radiol Oncol; 2020 Sep; 54(4):394-408. PubMed ID: 32990651
[TBL] [Abstract][Full Text] [Related]
19. Quantification of diffusion and anisotropy in intracranial epidermoids using diffusion tensor metrics and p: q tensor decomposition.
Srinivasan K; Thomas B; Shah D; Kannath SK; Menon G; Sandhyamani S; Kesavadas C; Kapilamoorthy TR
J Neuroradiol; 2016 Dec; 43(6):363-370. PubMed ID: 27318387
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.
Buemi F; Guzzardi G; Del Sette B; Sponghini AP; Matheoud R; Soligo E; Trisoglio A; Carriero A; Stecco A
Neuroradiol J; 2019 Aug; 32(4):241-249. PubMed ID: 31066622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
